| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |